XSHQ Invesco S&P SmallCap Quality ETF

Expense Ratio
0.29%
Dividend
1.50%
Previous close
$42.24
Est. 12 months change
+20.11%
Projected Price
$50.73

Profitability Metrics

Return on Equity (ROE)
30.31%
Return on Assets (ROA)
9.11%
Return on Invested Capital (ROIC)
21.78%
Weighted Average Cost of Capital (WACC)
9.10%
ROIC - WACC
12.69%
Updated : 2026-04-04 07:09 ET

Valuation Metrics

P/E Ratio
15.62
Forward P/E
13.56
PEG Ratio
1.58
Debt Current Ratio
2.59

Growth & Cash Flow

Gross Margin
46.63%
Operating Margin
20.53%
FCF Margin
19.18%
TTM Revenue Growth
12.82%
Projected 12M EPS Growth
15.18%

Price Change

Price % from 50 SMA
-2.58%
Price % from 200 SMA
-1.08%
6 Months
-1.93%
1 Year
6.42%
2 Years
5.21%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
EAT2.64%
YOU2.55%
AWI2.36%
PJT2.02%
TGTX1.97%
ECG1.85%
IBP1.79%
ZWS1.78%
MC1.77%
FSS1.74%

ETF Analysis

Fund Overview

Invesco S&P SmallCap Quality ETF (XSHQ) currently reports 117 stock positions (subject to change), placing it in the highly diversified range by holdings breadth. The top line-up is EAT (2.64%), YOU (2.55%), AWI (2.36%), with EAT as the largest single weight at 2.64%. Together, the top three holdings account for 7.55%, which implies a more democratized weight structure where the broader holding set matters as much as the leadership group. This structure gives the portfolio a dual character: meaningful exposure to its highest-conviction names, alongside enough breadth to dampen idiosyncratic noise.

Profitability & Capital Efficiency

Examining the portfolio through a capital allocation lens, ROIC is 21.78%, WACC is 9.10%, and the economic spread is 12.69%. On balance, the spread between ROIC and WACC is solidly positive — reinvestment is adding value rather than diluting it. Supporting metrics show ROE at 30.31% and ROA at 9.11%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.

Valuation

Valuation currently screens at trailing P/E of 15.62, forward P/E of 13.56, PEG of 1.58. Trailing and forward P/E are close together, implying the market does not expect a significant change in the earnings trajectory over the near term. Growth-adjusted valuation is in a reasonable range, with the multiple broadly in line with expected earnings expansion. The aggregate current ratio of 2.59 reflects a holding set with strong liquidity buffers against short-term stress. The valuation profile here is neither obviously cheap nor dramatically expensive — a setup where the return case is built more on earnings delivery than on re-rating potential.

Margins & Cash Generation

From gross to free cash flow, gross margin sits at 46.63%, operating margin at 20.53%, and free cash flow margin at 19.18%. At this gross margin level, the holdings demonstrate adequate production efficiency without commanding premium pricing. The operating margin reading is healthy — adequate to support reinvestment without sacrificing profitability. The portfolio's FCF margin is above average, pointing to holdings with efficient capital deployment and durable cash generation. The margin profile warrants careful consideration — businesses with compressed margins have less room to absorb cost pressure or revenue softness.

Growth & Forward Outlook

Combining revenue momentum with analyst targets, the estimated 12-month price change of 20.31%, where consensus expectations favor gradual appreciation over the next year, while TTM revenue growth of 12.82% reflecting moderate but reliable revenue progress across the basket. Separating operating reality from market-implied expectations is useful here — they can diverge meaningfully when sentiment shifts. The forward return case hinges on whether the operating reality stays close enough to analyst assumptions for those targets to remain credible. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Buy

The fundamental case holds up across most key dimensions — the combination of positive economic spread, reasonable valuation, and analyst support is constructive.

These findings are based solely on the metrics presented and do not constitute an investment recommendation. Always perform your own due diligence before committing capital.